Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30026962HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS30026963HIVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20001445HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20001070HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20041095HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20038300HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20046168HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20044845HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20042956HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20065709HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB00622
Drug NameNicardipine
Target IDBE0000045
UniProt IDP20309
Regulation Typeantagonist
PubMed IDs2981533
CitationsThayer SA, Welcome M, Chhabra A, Fairhurst AS: Effects of dihydropyridine calcium channel blocking drugs on rat brain muscarinic and alpha-adrenergic receptors. Biochem Pharmacol. 1985 Jan 15;34(2):175-80.
GroupsApproved; Investigational
Direct ClassificationDihydropyridinecarboxylic acids and derivatives
SMILESCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OCCN(C)CC1=CC=CC=C1
Pathways
PharmGKBPA450620
ChEMBLCHEMBL1484